MORRISTOWN, N.J., June 1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that Columbia Laboratories, Inc. has filed with the ...
Columbia Labs’ Crinone is a vaginal progesterone gel which utilizes the company’s proprietary sustained-release bioadhesive technology. The product is currently approved in more than 60 countries. US ...
- Established, patient-preferred infertility treatment - - Expands Watson's Women's Health brand product portfolio - - Preterm birth clinical trials currently underway - - Company acquires 11.2 ...
LIVINGSTON, N.J.--(BUSINESS WIRE)-- Columbia Laboratories, Inc. (Nasdaq: CBRX) has renewed its license and supply agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, for CRINONE ...
The Company's revenue streams include sales and royalty revenues from CRINONE® 8% (progesterone gel), which is marketed by Actavis, Inc. in the United States and by Merck Serono S.A. in over 60 ...
LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) has amended its license and supply agreement with Merck Serono, a division of Merck KGaA (XETRA: MRK.DE), Darmstadt, ...
Co announces that an interim analysis of a pregnancy study comparing the efficacy of Crinone 8% to compounded intramuscular progesterone injections is now available online and will be published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback